A Critical Analysis of New Molecular Targets and Strategies for Drug Developments in Alzheimers Disease
Journal:
Current Drug Targets
Volume:
4
Page:
97-112
Author(s):
Debomoy K. Lahiri, Martin R. Farlow, Kumar Sambamurti, Nigel H. Greig, Ezio Giacobini and Lon S. Schneider
Emerging β-Amyloid Therapies for the Treatment of Alzheimers Disease
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
427-447
Author(s):
Kelly A. Conway, Ellen W. Baxter, Kevin M. Felsenstein and Allen B. Reitz
Novel Approaches to Cancer Therapy Using Oncolytic Viruses
Journal:
Current Molecular Medicine
Volume:
3
Page:
61-71
Author(s):
S. F. Stanziale and Y. Fong
The Cytokine Network in HIV Infection
Journal:
Current Molecular Medicine
Volume:
2
Page:
677-689
Author(s):
M. Alfano and G. Poli
Herpes Simplex Virus Vectors for Gene Delivery to a Variety of Different Cell Types
Journal:
Current Gene Therapy
Volume:
2
Page:
415-426
Author(s):
David S. Latchman
Gene Therapy and Biologic Therapy with Interleukin?4
Journal:
Current Gene Therapy
Volume:
2
Page:
437-450
Author(s):
Hideho Okada and Naruo Kuwashima
Neuroprotective Gene Therapy for Parkinson’s Disease
Journal:
Current Gene Therapy
Volume:
2
Page:
451-483
Author(s):
L. Tenenbaum, A. Chtarto, E. Lehtonen, D. Blum, V. Baekelandt, T. Velu, J. Brotchi and M. Levivier
Cytosolic Phospholipase A2 Inhibitors as Therapeutic Agents for Neural Cell Injury
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
193-204
Author(s):
A. A. Farooqui, Wei-YiOng, X.- R. Lu and L. A. Horrocks
Role of CD14 in Host Response to Infection
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
205-210
Author(s):
A. Verbon
Inhibitor at the Gates, Inhibitor in the Chamber: Allosteric and Competitive Inhibitors of the Proteasome as Prospective Drugs
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
279-301
Author(s):
M. Gaczynska and P.A. Osmulski